Page last updated: 2024-08-21

2,3-dimethylmaleic anhydride and Liver Neoplasms

2,3-dimethylmaleic anhydride has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Li, XX; Ma, JB; Shen, JM; Zhang, SQ; Zhu, ZY; Zhuang, R1

Other Studies

1 other study(ies) available for 2,3-dimethylmaleic anhydride and Liver Neoplasms

ArticleYear
pH-Sensitive nanoparticles as smart carriers for selective intracellular drug delivery to tumor.
    International journal of pharmaceutics, 2018, Jul-10, Volume: 545, Issue:1-2

    Topics: Animals; Antibiotics, Antineoplastic; Cell-Penetrating Peptides; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Hep G2 Cells; Humans; Hydrogen-Ion Concentration; Liver Neoplasms; Male; Maleic Anhydrides; Mice; Nanoparticles; Nanotechnology; Peptide Fragments; Polyethylene Glycols; Polylysine; tat Gene Products, Human Immunodeficiency Virus; Technology, Pharmaceutical; Tissue Distribution; Tumor Burden

2018